Healthcare

Senate Bill 32 amends Michigan's insurance code to require insurers offering medical malpractice policies to annually provide specific information. These insurers must submit data about their policies related to perinatal care services to the Department in a manner it determines. Within 60 days, the Department must then forward this information to the Department of Health and Human Services. This data sharing is intended to support a study required under the public health code. The bill will not take effect unless Senate Bill No. 29 also becomes law.

SB 94 prohibits drug manufacturers, wholesalers, and distributors from restricting 340B program pharmacies from accessing or receiving 340B drugs, which are discounted medications for safety-net healthcare providers. It requires 340B entities (like community health centers) to submit annual compliance reports starting in 2026, including program audits and community impact details. Additionally, drug manufacturers must report price increases exceeding 15% for drugs costing over $40 per treatment course, including cost data and patent details. These provisions directly affect pharmaceutical companies, participating pharmacies, and healthcare providers enrolled in the federal 340B drug pricing program.